These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The Longitudinal Immune Response to Coronavirus Disease 2019: Chasing the Cytokine Storm. Chau AS; Weber AG; Maria NI; Narain S; Liu A; Hajizadeh N; Malhotra P; Bloom O; Marder G; Kaplan B Arthritis Rheumatol; 2021 Jan; 73(1):23-35. PubMed ID: 32929876 [TBL] [Abstract][Full Text] [Related]
3. The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives. Boechat JL; Chora I; Morais A; Delgado L Pulmonology; 2021; 27(5):423-437. PubMed ID: 33867315 [TBL] [Abstract][Full Text] [Related]
4. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting. Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J Front Immunol; 2021; 12():802858. PubMed ID: 35003131 [TBL] [Abstract][Full Text] [Related]
5. Hyperinflammatory Immune Response and COVID-19: A Double Edged Sword. Tan LY; Komarasamy TV; Rmt Balasubramaniam V Front Immunol; 2021; 12():742941. PubMed ID: 34659238 [TBL] [Abstract][Full Text] [Related]
6. Innate and adaptive immune responses to SARS-CoV-2 in humans: relevance to acquired immunity and vaccine responses. Jordan SC Clin Exp Immunol; 2021 Jun; 204(3):310-320. PubMed ID: 33534923 [TBL] [Abstract][Full Text] [Related]
7. Impaired Cellular Immunity to SARS-CoV-2 in Severe COVID-19 Patients. Ni L; Cheng ML; Feng Y; Zhao H; Liu J; Ye F; Ye Q; Zhu G; Li X; Wang P; Shao J; Deng YQ; Wei P; Chen F; Qin CF; Wang G; Li F; Zeng H; Dong C Front Immunol; 2021; 12():603563. PubMed ID: 33603759 [TBL] [Abstract][Full Text] [Related]
8. Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal Cohort. Vo HTM; Maestri A; Auerswald H; Sorn S; Lay S; Seng H; Sann S; Ya N; Pean P; Dussart P; Schwartz O; Ly S; Bruel T; Ly S; Duong V; Karlsson EA; Cantaert T Front Immunol; 2022; 13():817905. PubMed ID: 35185909 [TBL] [Abstract][Full Text] [Related]
9. Interrogation of the cellular immunome of cancer patients with regard to the COVID-19 pandemic. Donahue RN; Marté JL; Goswami M; Toney NJ; Tsai YT; Gulley JL; Schlom J J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33707314 [TBL] [Abstract][Full Text] [Related]
10. Assessment of SARS-CoV-2 Immunity in Convalescent Children and Adolescents. Tsang HW; Chua GT; To KKW; Wong JSC; Tu W; Kwok JSY; Wong WHS; Wang X; Zhang Y; Rosa Duque JS; Chan GCF; Chu WK; Pang CP; Tam PKH; Lau YL; Wong ICK; Leung WH; Yuen KY; Kwan MYW; Ip P Front Immunol; 2021; 12():797919. PubMed ID: 34975908 [TBL] [Abstract][Full Text] [Related]
11. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome. Azar MM; Shin JJ; Kang I; Landry M Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479 [TBL] [Abstract][Full Text] [Related]
12. Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology. Song NJ; Allen C; Vilgelm AE; Riesenberg BP; Weller KP; Reynolds K; Chakravarthy KB; Kumar A; Khatiwada A; Sun Z; Ma A; Chang Y; Yusuf M; Li A; Zeng C; Evans JP; Bucci D; Gunasena M; Xu M; Liyanage NPM; Bolyard C; Velegraki M; Liu SL; Ma Q; Devenport M; Liu Y; Zheng P; Malvestutto CD; Chung D; Li Z J Hematol Oncol; 2022 Jan; 15(1):5. PubMed ID: 35012610 [TBL] [Abstract][Full Text] [Related]
13. Immunopathology of Hyperinflammation in COVID-19. Gustine JN; Jones D Am J Pathol; 2021 Jan; 191(1):4-17. PubMed ID: 32919977 [TBL] [Abstract][Full Text] [Related]
14. An Impaired Inflammatory and Innate Immune Response in COVID-19. Park SH Mol Cells; 2021 Jun; 44(6):384-391. PubMed ID: 34098591 [TBL] [Abstract][Full Text] [Related]
15. Immune response to COVID-19 infection: a double-edged sword. Saad N; Moussa S Immunol Med; 2021 Sep; 44(3):187-196. PubMed ID: 33444511 [TBL] [Abstract][Full Text] [Related]
16. How could we forget immunometabolism in SARS-CoV2 infection or COVID-19? Kumar V Int Rev Immunol; 2021; 40(1-2):72-107. PubMed ID: 33155525 [TBL] [Abstract][Full Text] [Related]
17. Dysregulated Innate and Adaptive Immune Responses Discriminate Disease Severity in COVID-19. Janssen NAF; Grondman I; de Nooijer AH; Boahen CK; Koeken VACM; Matzaraki V; Kumar V; He X; Kox M; Koenen HJPM; Smeets RL; Joosten I; Brüggemann RJM; Kouijzer IJE; van der Hoeven HG; Schouten JA; Frenzel T; Reijers MHE; Hoefsloot W; Dofferhoff ASM; van Apeldoorn MJ; Blaauw MJT; Veerman K; Maas C; Schoneveld AH; Hoefer IE; Derde LPG; van Deuren M; van der Meer JWM; van Crevel R; Giamarellos-Bourboulis EJ; Joosten LAB; van den Heuvel MM; Hoogerwerf J; de Mast Q; Pickkers P; Netea MG; van de Veerdonk FL J Infect Dis; 2021 Apr; 223(8):1322-1333. PubMed ID: 33524124 [TBL] [Abstract][Full Text] [Related]
18. Age-related differences in the immune response could contribute to determine the spectrum of severity of COVID-19. Costagliola G; Spada E; Consolini R Immun Inflamm Dis; 2021 Jun; 9(2):331-339. PubMed ID: 33566457 [TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19. Wu Y; Huang X; Sun J; Xie T; Lei Y; Muhammad J; Li X; Zeng X; Zhou F; Qin H; Shao L; Zhang Q mSphere; 2020 Jul; 5(4):. PubMed ID: 32669467 [TBL] [Abstract][Full Text] [Related]
20. On the genetics and immunopathogenesis of COVID-19. Jacob CO Clin Immunol; 2020 Nov; 220():108591. PubMed ID: 32920210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]